Volume 95, Supplement 1 , Pages S247-S257, November 2006
Quality of Life Considerations in Gynecologic Cancer
Abstract
Quality of life (QOL) is a fundamental consideration for patients with life threatening diseases. Major evolving paradigms are discussed: improved QOL with laparoscopic surgery, the impact on QOL of intraperitoneal chemotherapy for optimally cytoreduced ovarian cancer, combination therapy, sexuality, and survivorship. The goals of treatment for many patients with gynecologic tumors remain largely palliative, and patient reported QOL is the primary outcome determining the utility of treatment. Particularly in this area, QOL endpoints are increasingly important in clinical trials. The QOL issues facing gynecologic cancer patients, the use of validated QOL instruments, recent advances in the evaluation of interventions, and changes in concepts related to QOL are reviewed.
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
PII: S0020-7292(06)60040-4
doi:10.1016/S0020-7292(06)60040-4
© 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Inc. All rights reserved.
Volume 95, Supplement 1 , Pages S247-S257, November 2006
